SCHEMBL6893683

SCHEMBL6893683

O=C(CN1CCNCCN(CC(=O)N(CC(=O)Nc2ccccc2)c2ccccc2)CC1)Nc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
CHRNB2 P17787 2/20 0.51
CHRNB4 P30926 2/20 0.51
CHRNA3 P32297 2/20 0.51
CHRNA4 P43681 2/20 0.51
NPC1 O15118 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TP53 P04637 1/20 0.49
RAB9A P51151 1/20 0.49
ME2 P23368 1/20 0.48
ME1 P48163 1/20 0.48
ME3 Q16798 1/20 0.48
REV1 Q9UBZ9 1/20 0.47
KCNA5 P22460 1/20 0.47
NPSR1 Q6W5P4 2/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL793647 0.84 ALDH1A1 (0.68) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA4
Hydrochloric Acid SCHEMBL210978 0.83 ALDH1A1 (0.67) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL6893687 0.77 ALDH1A1 (0.79) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL4558670 0.76 ALDH1A1 (0.50) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL9157740 0.75 KMT2A (0.66) ALDH1A1NPC1KDM4EMEN1KMT2A
SCHEMBL5336810 0.73 ALDH1A1 (0.74) ALDH1A1NPC1MEN1KMT2ALMNA
SCHEMBL14192211 0.73 ALDH1A1 (0.72) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL9099124 0.72 KDM4E (0.42) ALDH1A1NPC1KDM4EMEN1KMT2A
SCHEMBL7282542 0.72 SIGMAR1 (0.58) ALDH1A1NPC1MEN1KMT2ATP53
SCHEMBL7278718 0.72 ALDH1A1 (0.62) ALDH1A1NPC1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5874573-A Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy CONCAT, INC. (US) 1999-02-23 US claimed
EP-1382332-A1 Method for inhibiting bacterial or fungal growth using a polyamine derivative as complexing agent Chelator LLC (US) 2004-01-21 EP disclosed
US-6469162-B1 SUCH COMPOUNDS INHIBIT MAMMALIAN, BACTERIAL, AND FUNGAL CELL REPLICATION AND ARE USEFUL IN THE TREATMENT OF NEOPLASIA, INFECTION, INFLAMMATION, IMMUNE REPONSE, AND IN TERMINATION OF PREGNANCY CONCAT, LTD. 2002-10-22 US disclosed
US-6165996-A Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis CONCAT, INC. (US) 2000-12-26 US disclosed
EP-0955044-A2 Method of inhibiting bacterial or fungal growth using a complexing agent CONCAT LTD. (US) 1999-11-10 EP disclosed
EP-0841951-A2 COMPOUNDS WITH CHELATION AFFINITY AND SELECTIVITY FOR FIRST TRANSITION SERIES ELEMENTS, AND THEIR USE IN MEDICAL THERAPY AND DIAGNOSIS CONCAT LTD. (US) 1998-05-20 EP disclosed
WO-1997001360-A9 COMPOUNDS WITH CHELATION AFFINITY AND SELECTIVITY FOR FIRST TRANSITION SERIES ELEMENTS AND THEIR USE IN MEDICAL THERAPY AND DIAGNOSIS 1997-07-17 WO disclosed
WO-1997001360-A2 COMPOUNDS WITH CHELATION AFFINITY AND SELECTIVITY FOR FIRST TRANSITION SERIES ELEMENTS AND THEIR USE IN MEDICAL THERAPY AND DIAGNOSIS CONCAT, LTD. (US) 1997-01-16 WO disclosed